Showa University Koto Toyosu Hospital
Koto Ku, Tokyo, Japan
University hospital in the Koto, Tokyo
5 Chome-1-38 Toyosu, Koto City, Tokyo 135-8577
About Showa University Koto Toyosu Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Showa University Koto Toyosu Hospital
During the past decade, Showa University Koto Toyosu Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)
2007-01-01
2015-04-01
Completed
1,513
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
2005-12-01
2008-04-01
Terminated
165
Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
2007-09-01
2009-10-01
Terminated
153
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
2013-06-27
2020-11-12
Completed
2,877
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Showa University Koto Toyosu Hospital" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Bayer" with 2 trials
sponsored, "Daiichi Sankyo Co., Ltd." with 1 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored and "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Showa University Koto Toyosu Hospital"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Nektar Therapeutics" with 1 trials as a collaborator and "Tokyo Medical and Dental University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Showa University Koto Toyosu Hospital
According to Clinical.Site data, the most researched conditions in "Showa University Koto Toyosu Hospital" are
"Ulcerative Colitis" (3 trials), "Anemia" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Atrial Fibrillation" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Showa University Koto Toyosu Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Showa University Koto Toyosu Hospital
Most popular intervention types in "Showa University Koto Toyosu Hospital" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Mirikizumab" (3 trials), "Placebo" (3 trials), "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials) and "DS-8201a" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Showa University Koto Toyosu Hospital
The vast majority of trials in "Showa University Koto Toyosu Hospital" are
10 trials for "All" genders.
Clinical Trials Status at Showa University Koto Toyosu Hospital
Currently, there are NaN active trials in "Showa University Koto Toyosu Hospital".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Showa University Koto Toyosu Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Showa University Koto Toyosu Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".